NorthStar signs exclusive radioisotope distribution, marketing agreement with GE Healthcare

A radioactive isotope in the lab.

NorthStar Medical Radioisotopes has signed an exclusive agreement with GE Healthcare Systems to market and distribute Iodine-123 (I-123), a radioisotope used routinely in nuclear medicine, the Beloit-based radiopharmaceutical company announced today. Under the terms of the contract, GE Healthcare Systems’ Pharmaceutical Diagnostics unit will manufacture I-123 capsules at its production facility in Arlington Heights, Illinois.

Want to Read the Entire Article?

Become a BizTimes Insider today and get immediate access to our subscriber-only content and much more.

Become an Insider Now

Already an Insider? Log In

Or purchase a bypass link here

Sign up for BizTimes Daily Alerts

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

No posts to display